North Rock Partners, LLC Petros Pharmaceuticals, Inc. Transaction History

North Rock Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$1.33 - $4.09 $153,342 - $471,556	-115,295 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.82 - $3.2 $189,085 - $332,457	-103,893 Reduced 47.4%	115,295 $431,000
Q2 2021 Aug 12, 2021	SELL	$2.87 - $4.11 $339,644 - $486,389	-118,343 Reduced 35.06%	219,188 $686,000
Q1 2021 May 11, 2021	SELL	$2.85 - $4.6 $135,375 - $218,499	-47,500 Reduced 12.34%	337,531 $1.26 Million
Q4 2020 Feb 08, 2021	BUY	$3.24 - $4.68 $1.25 Million - $1.8 Million	385,031 New	385,031 $1.69 Million

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $5.18M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on North Rock Partners, LLC with notifications on news.